drugset / Trial / NCT00004440

Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis

NCT00004440

RandomizedOpen-labelTreatment

Summary

OBJECTIVES: I. Determine the effect of different doses of ibuprofen on neutrophil (polymorphonuclear leukocyte; PMN) delivery to a mucosal surface (the oral mucosa) in patients with cystic fibrosis and healthy controls. II. Determine the duration of effect (and possible rebound effect) of ibuprofen on PMN delivery to a mucosal surface in these patients.

Timeline

Start
1996-08
Primary completion
Completion
1999-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule Oral

Indications